SCHEMBL6400618

SCHEMBL6400618

C=CCSc1ncc2cccnc2n1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.39
HPGD P15428 2/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 3/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4761063 0.78 L3MBTL1 (0.50) L3MBTL1TP53GAAHPGDRAB9A
SCHEMBL14699551 0.78 L3MBTL1 (0.57) L3MBTL1TP53GAAHPGDRAB9A
SCHEMBL692444 0.73 L3MBTL1 (0.58) L3MBTL1TP53GAAHPGDRAB9A
SCHEMBL18193691 0.73 RPS6KA5 (0.41) TP53RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL14805666 0.69 ALDH1A1 (0.35) TP53GAAKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2563787 0.69 ALDH1A1 (0.45) L3MBTL1TP53GAAHPGDRAB9A
SCHEMBL11853838 0.69 L3MBTL1 (0.46) L3MBTL1TP53GAAHPGDRAB9A
SCHEMBL8571213 0.68 ALDH1A1 (0.35) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL6336905 0.68 TSHR (0.39) L3MBTL1GAAHPGDRAB9AKDM4E
SCHEMBL4311403 0.67 GAA (0.49) L3MBTL1TP53GAAHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417207-B1 PROCESS FOR PREPARING 2-(4-PYRIDYL) AMINO-6-DIALKYLOXYPHENYL-PYRIDO(2,3-D)PYRIMIDIN-7-ONES WARNER LAMBERT CO (US) 2005-08-31 EP claimed
US-6900316-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones WARNER-LAMBER COMPANY (US) 2005-05-31 US claimed
EP-1417207-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL) AMINO-6-DIALKYLOXYPHENYL-PYRIDO(2,3-D)PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2004-05-12 EP claimed
US-20030176700-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones TJIONG HOWARD ISAAC (US) 2003-09-18 US claimed
WO-2003027110-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL) AMINO-6-DIALKYLOXYPHENYL-PYRIDO [2,3-D]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2003-04-03 WO claimed
US-6960662-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones WARNER-LAMBERT COMPANY (US) 2005-11-01 US disclosed
EP-1417207-B1 PROCESS FOR PREPARING 2-(4-PYRIDYL) AMINO-6-DIALKYLOXYPHENYL-PYRIDO(2,3-D)PYRIMIDIN-7-ONES WARNER LAMBERT CO (US) 2005-08-31 EP disclosed
US-6900316-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones WARNER-LAMBER COMPANY (US) 2005-05-31 US disclosed
US-6900316-B2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones WARNER-LAMBER COMPANY (US) 2005-05-31 US disclosed
EP-1417207-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL) AMINO-6-DIALKYLOXYPHENYL-PYRIDO(2,3-D)PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2004-05-12 EP disclosed
US-20030216415-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones BEYLIN VLADIMIR GENUKH (US) 2003-11-20 US disclosed
US-20030176700-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones TJIONG HOWARD ISAAC (US) 2003-09-18 US disclosed
WO-2003027110-A2 PROCESS FOR PREPARING 2-(4-PYRIDYL) AMINO-6-DIALKYLOXYPHENYL-PYRIDO [2,3-D]PYRIMIDIN-7-ONES WARNER-LAMBERT COMPANY (US) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176700-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones DPYD, PDXK, AHR L3MBTL1 4253/4885TP53 1771/4885GAA 4497/4885
US-20030216415-A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones DPYD, PDXK, PARP2 L3MBTL1 4495/4885TP53 2062/4885GAA 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.